- Home
- NVCR vs CLOV Comparison
NVCR vs CLOV Comparison
Compare NVCR & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVCR | CLOV |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.8B |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NVCR | CLOV |
|---|---|---|
| Price | $17.90 | $3.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $28.08 | $2.90 |
| AVG Volume (30 Days) | 1.8M | ★ 6.8M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 21.79 | ★ 38.03 |
| EPS | N/A | ★ 0.05 |
| Revenue | $655,353,000.00 | ★ $1,924,308,000.00 |
| Revenue This Year | $7.72 | $52.59 |
| Revenue Next Year | $6.74 | $15.37 |
| P/E Ratio | ★ N/A | $71.70 |
| Revenue Growth | 8.28 | ★ 40.34 |
| 52 Week Low | $9.82 | $1.58 |
| 52 Week High | $20.05 | $3.92 |
Technical Indicators
Market Signals| Indicator | NVCR | CLOV |
|---|---|---|
| Relative Strength Index (RSI) | 66.10 | 77.41 |
| Support Level | $12.48 | $2.44 |
| Resistance Level | $18.92 | $3.70 |
| Average True Range (ATR) | 0.90 | 0.21 |
| MACD | -0.08 | 0.03 |
| Stochastic Oscillator | 70.74 | 87.17 |
Price Performance
Historical ComparisonAbout NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.